These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 374421
1. The presence and significance of the Thomsen-Friedenreich antigen in breast cancer. I. Serological studies. Newman RA, Klein PJ, Uhlenbruck G, Citoler P, Karduck D. J Cancer Res Clin Oncol; 1979 Feb 19; 93(2):181-8. PubMed ID: 374421 [Abstract] [Full Text] [Related]
2. The presence and significance of the Thomsen-Friedenreich antigen in mammary gland. II. Its topochemistry in normal, hyperplastic and carcinoma tissue of the breast. Klein PJ, Newman RA, Müller P, Uhlenbruck G, Citoler P, Schaefer HE, Lennartz KJ, Fischer R. J Cancer Res Clin Oncol; 1979 Feb 19; 93(2):205-14. PubMed ID: 438283 [Abstract] [Full Text] [Related]
3. The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer. Kurtenkov O, Innos K, Sergejev B, Klaamas K. Biomed Res Int; 2018 Feb 19; 2018():9579828. PubMed ID: 30105268 [Abstract] [Full Text] [Related]
4. [ELISA of IgM antibodies to Thomsen-Friedenreich (TF) hapten in cancer diagnostics: comparison of data obtained with four TF-glycoconjugates]. Smorodin EP, Jansson B, Miliukhina L, Paaski G, Bovin NV, Ovchinnikova TV, Kurtenkov O. Bioorg Khim; 1997 Oct 19; 23(10):795-9. PubMed ID: 9490614 [Abstract] [Full Text] [Related]
5. Detection of metastatic breast carcinoma cells by immunofluorescent demonstration of Thomsen-Friedenreich antigen. Seitz RC, Fischer K, Stegner HE, Poschmann A. Cancer; 1984 Sep 01; 54(5):830-6. PubMed ID: 6331628 [Abstract] [Full Text] [Related]
6. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection. Kumar SR, Sauter ER, Quinn TP, Deutscher SL. Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6868-71. PubMed ID: 16203776 [Abstract] [Full Text] [Related]
7. Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigen. Springer GF, Murthy MS, Desai PR, Scanlon EF. Cancer; 1980 Jun 15; 45(12):2949-54. PubMed ID: 6248184 [Abstract] [Full Text] [Related]
8. Histochemical methods for the demonstration of Thomsen-Friedenreich antigen in cell suspensions and tissue sections. [Klin. Wochenschr. 56, 761--765 (1978)]. Springer GF, Desai PR, Murthy MS. Klin Wochenschr; 1978 Dec 15; 56(24):1225-6. PubMed ID: 732244 [No Abstract] [Full Text] [Related]
9. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. Springer GF, Desai PR, Banatwala I. J Natl Cancer Inst; 1975 Feb 15; 54(2):335-9. PubMed ID: 163330 [Abstract] [Full Text] [Related]
10. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection. Desai PR, Ujjainwala LH, Carlstedt SC, Springer GF. J Immunol Methods; 1995 Dec 27; 188(2):175-85. PubMed ID: 8551046 [Abstract] [Full Text] [Related]
11. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. Campbell BJ, Finnie IA, Hounsell EF, Rhodes JM. J Clin Invest; 1995 Feb 27; 95(2):571-6. PubMed ID: 7860740 [Abstract] [Full Text] [Related]
12. IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival. Kurtenkov O, Klaamas K, Rittenhouse-Olson K, Vahter L, Sergejev B, Miljukhina L, Shljapnikova L. Exp Oncol; 2005 Jun 27; 27(2):136-40. PubMed ID: 15995632 [Abstract] [Full Text] [Related]
13. Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them. Springer GF, Desai PR, Scanlon EF. Cancer; 1976 Jan 27; 37(1):169-76. PubMed ID: 55297 [Abstract] [Full Text] [Related]
14. Signatures of anti-Thomsen - Friedenreich antigen antibody diversity in colon cancer patients. Kurtenkov O, Bubina M, Klaamas K. Exp Oncol; 2018 Mar 27; 40(1):48-58. PubMed ID: 29600973 [Abstract] [Full Text] [Related]
15. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen. Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Sommer H, Friese K. Histochem Cell Biol; 2005 Jun 27; 123(6):631-7. PubMed ID: 15889266 [Abstract] [Full Text] [Related]
16. Expression of peanut agglutinin-binding mucin-type glycoprotein in human esophageal squamous cell carcinoma as a marker. Kannan S, Lakku RA, Niranjali D, Jayakumar K, Steven AH, Taralakshmi VV, Chandramohan S, Balakrishnan R, Schmidt C, Halagowder D. Mol Cancer; 2003 Nov 05; 2():38. PubMed ID: 14613581 [Abstract] [Full Text] [Related]
17. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma. Holder WD, Wells SA. Cancer Res; 1983 Jan 05; 43(1):239-44. PubMed ID: 6291754 [Abstract] [Full Text] [Related]
18. Increased expression of Thomsen-Friedenreich antigens during tumor progression in breast cancer patients. Wolf MF, Ludwig A, Fritz P, Schumacher K. Tumour Biol; 1988 Jan 05; 9(4):190-4. PubMed ID: 3420374 [Abstract] [Full Text] [Related]
19. Antibodies to mouse mammary tumor virus-related antigen in sera of patients with breast carcinoma. Tomana M, Kajdos AH, Niedermeier W, Durkin WJ, Mestecky J. Cancer; 1981 Jun 01; 47(11):2696-703. PubMed ID: 6266639 [Abstract] [Full Text] [Related]
20. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. Hanisch FG, Baldus SE. Histol Histopathol; 1997 Jan 01; 12(1):263-81. PubMed ID: 9046061 [Abstract] [Full Text] [Related] Page: [Next] [New Search]